Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients.
atrial fibrillation
atrial fibrillation type
death
outcomes
progression
registry
remodeling
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
18 Jan 2023
18 Jan 2023
Historique:
received:
10
12
2022
revised:
28
12
2022
accepted:
11
01
2023
entrez:
11
2
2023
pubmed:
12
2
2023
medline:
12
2
2023
Statut:
epublish
Résumé
Paroxysmal atrial fibrillation (AF) may often progress towards more sustained forms of the arrhythmia, but further research is needed on the factors associated with this clinical course. We analyzed patients enrolled in a prospective cohort study of AF patients. Patients with paroxysmal AF at baseline or first-detected AF (with successful cardioversion) were included. According to rhythm status at 1 year, patients were stratified into: (i) No AF progression and (ii) AF progression. All-cause death was the primary outcome. A total of 2688 patients were included (median age 67 years, interquartile range 60-75, females 44.7%). At 1-year of follow-up, 2094 (77.9%) patients showed no AF progression, while 594 (22.1%) developed persistent or permanent AF. On multivariable logistic regression analysis, no physical activity (odds ratio [OR] 1.35, 95% CI 1.02-1.78), valvular heart disease (OR 1.63, 95% CI 1.23-2.15), left atrial diameter (OR 1.03, 95% CI 1.01-1.05), or left ventricular ejection fraction (OR 0.98, 95% CI 0.97-1.00) were independently associated with AF progression at 1 year. After the assessment at 1 year, the patients were followed for an extended follow-up of 371 days, and those with AF progression were independently associated with a higher risk for all-cause death (adjusted hazard ratio 1.77, 95% CI 1.09-2.89) compared to no-AF-progression patients. In a contemporary cohort of AF patients, a substantial proportion of patients presenting with paroxysmal or first-detected AF showed progression of the AF pattern within 1 year, and clinical factors related to cardiac remodeling were associated with progression. AF progression was associated with an increased risk of all-cause mortality.
Sections du résumé
BACKGROUND
BACKGROUND
Paroxysmal atrial fibrillation (AF) may often progress towards more sustained forms of the arrhythmia, but further research is needed on the factors associated with this clinical course.
METHODS
METHODS
We analyzed patients enrolled in a prospective cohort study of AF patients. Patients with paroxysmal AF at baseline or first-detected AF (with successful cardioversion) were included. According to rhythm status at 1 year, patients were stratified into: (i) No AF progression and (ii) AF progression. All-cause death was the primary outcome.
RESULTS
RESULTS
A total of 2688 patients were included (median age 67 years, interquartile range 60-75, females 44.7%). At 1-year of follow-up, 2094 (77.9%) patients showed no AF progression, while 594 (22.1%) developed persistent or permanent AF. On multivariable logistic regression analysis, no physical activity (odds ratio [OR] 1.35, 95% CI 1.02-1.78), valvular heart disease (OR 1.63, 95% CI 1.23-2.15), left atrial diameter (OR 1.03, 95% CI 1.01-1.05), or left ventricular ejection fraction (OR 0.98, 95% CI 0.97-1.00) were independently associated with AF progression at 1 year. After the assessment at 1 year, the patients were followed for an extended follow-up of 371 days, and those with AF progression were independently associated with a higher risk for all-cause death (adjusted hazard ratio 1.77, 95% CI 1.09-2.89) compared to no-AF-progression patients.
CONCLUSIONS
CONCLUSIONS
In a contemporary cohort of AF patients, a substantial proportion of patients presenting with paroxysmal or first-detected AF showed progression of the AF pattern within 1 year, and clinical factors related to cardiac remodeling were associated with progression. AF progression was associated with an increased risk of all-cause mortality.
Identifiants
pubmed: 36769416
pii: jcm12030768
doi: 10.3390/jcm12030768
pmc: PMC9917523
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Am J Physiol Heart Circ Physiol. 2020 Nov 1;319(5):H1051-H1058
pubmed: 32946289
Kardiol Pol. 2019 Dec 19;77(12):1119-1120
pubmed: 31855194
Heart. 2021 Oct;107(20):1630-1636
pubmed: 34261737
JACC Clin Electrophysiol. 2015 Jun;1(3):105-115
pubmed: 29759352
JAMA Cardiol. 2018 Jul 1;3(7):558-560
pubmed: 29799958
Card Electrophysiol Clin. 2021 Mar;13(1):201-209
pubmed: 33516398
Heart Rhythm. 2019 Apr;16(4):502-510
pubmed: 30366160
Eur J Clin Invest. 2022 Jun;52(6):e13751
pubmed: 35080269
Thromb Haemost. 2022 Mar;122(3):406-414
pubmed: 34020488
N Engl J Med. 2023 Jan 12;388(2):105-116
pubmed: 36342178
Eur Heart J Qual Care Clin Outcomes. 2022 Oct 26;8(7):778-786
pubmed: 34555148
Europace. 2018 May 1;20(5):747-757
pubmed: 29016832
Circulation. 1995 Oct 1;92(7):1954-68
pubmed: 7671380
Cardiovasc Res. 2021 Jun 16;117(7):1-21
pubmed: 33913486
Intern Emerg Med. 2020 Oct;15(7):1183-1192
pubmed: 32557091
Europace. 2018 Nov 1;20(11):1750-1757
pubmed: 29518195
Heart. 2022 Jul 20;:
pubmed: 35858774
Heart. 2018 Oct;104(19):1608-1614
pubmed: 29550771
Eur Heart J Suppl. 2020 Dec 22;22(Suppl O):O42-O52
pubmed: 33380943
N Engl J Med. 2020 Oct 1;383(14):1305-1316
pubmed: 32865375
Eur J Intern Med. 2021 Oct;92:100-106
pubmed: 34154879
Stroke. 2018 Oct;49(10):2301-2308
pubmed: 30355097
J Am Heart Assoc. 2019 Oct 15;8(20):e012554
pubmed: 31590581
J Am Coll Cardiol. 2010 Feb 23;55(8):725-31
pubmed: 20170808
Europace. 2020 Mar 1;22(3):352-360
pubmed: 31865391
BMC Med. 2021 Oct 20;19(1):256
pubmed: 34666757
Intern Emerg Med. 2021 Aug;16(5):1131-1140
pubmed: 33161524
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
Thromb Haemost. 2021 Mar;121(3):270-278
pubmed: 32838473
Eur J Intern Med. 2021 Apr;86:1-11
pubmed: 33518403
Sci Rep. 2019 Sep 13;9(1):13270
pubmed: 31519947
Eur Heart J. 2021 Sep 14;42(35):3541-3554
pubmed: 34333599
Europace. 2017 Apr 01;19(4):535-543
pubmed: 28431068
Intern Emerg Med. 2022 Jun;17(4):1001-1012
pubmed: 34855117
Clin Res Cardiol. 2022 Jan;111(1):70-84
pubmed: 34448931
J Cardiovasc Med (Hagerstown). 2022 Jun 1;23(6):359-362
pubmed: 35645026
Eur J Intern Med. 2022 Nov;105:54-62
pubmed: 36028394
Chest. 2010 Feb;137(2):263-72
pubmed: 19762550
Eur Heart J. 2010 Oct;31(19):2369-429
pubmed: 20802247
Chest. 2012 Feb;141(2):339-347
pubmed: 21622553
J Am Coll Cardiol. 2022 May 17;79(19):1932-1948
pubmed: 35550691
Heart Rhythm. 2017 Jun;14(6):801-807
pubmed: 28232263
Sci Rep. 2020 Nov 5;10(1):19224
pubmed: 33154443
Int J Cardiol. 2014 Dec 15;177(2):467-76
pubmed: 25443248